Company intelligence / Profile preview

Luoyang Huizhong Biotech

Ownership: Private
Employees: ~287
Development stage: Other

Overview

Luoyang Huizhong Biotech Co., Ltd. is a Chinese biotechnology company specializing in the research, development, production, and commercialization of high-end veterinary vaccines. Established in 2011 as a wholly-owned subsidiary of Pulike Biological Engineering, Inc., the company operates advanced manufacturing facilities in the Luolong High-tech Industrial Development Zone in Luoyang, Henan. Its product portfolio includes a wide range of poultry and swine vaccines, such as inactivated and live vaccines targeting Newcastle disease, avian influenza, porcine circovirus, and porcine pseudorabies. Luoyang Huizhong Biotech leverages advanced technologies like suspension cell culture and genetic engineering to deliver high-quality animal health solutions.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologic
Industry: Veterinary

Beyond the preview

Go deeper on Luoyang Huizhong Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luoyang Huizhong Biotech.